Oragenics Stock Market Value
| OGEN Stock | USD 0.66 0.01 1.54% |
| Symbol | Oragenics |
Will Biotechnology sector continue expanding? Could Oragenics diversify its offerings? Factors like these will boost the valuation of Oragenics. Anticipated expansion of Oragenics directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Oragenics data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Investors evaluate Oragenics using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Oragenics' intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Oragenics' market price to deviate significantly from intrinsic value.
It's important to distinguish between Oragenics' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Oragenics should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Oragenics' market price signifies the transaction level at which participants voluntarily complete trades.
Oragenics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Oragenics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Oragenics.
| 11/18/2025 |
| 02/16/2026 |
If you would invest 0.00 in Oragenics on November 18, 2025 and sell it all today you would earn a total of 0.00 from holding Oragenics or generate 0.0% return on investment in Oragenics over 90 days. Oragenics is related to or competes with AIM ImmunoTech, Kala Pharmaceuticals, Ensysce Biosciences, Soligenix, Can Fite, Xenetic Biosciences, and CNS Pharmaceuticals. Oragenics, Inc. develops antibiotics for infectious diseases in the United States More
Oragenics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Oragenics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Oragenics upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.16) | |||
| Maximum Drawdown | 24.7 | |||
| Value At Risk | (8.33) | |||
| Potential Upside | 7.32 |
Oragenics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Oragenics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Oragenics' standard deviation. In reality, there are many statistical measures that can use Oragenics historical prices to predict the future Oragenics' volatility.| Risk Adjusted Performance | (0.11) | |||
| Jensen Alpha | (0.79) | |||
| Total Risk Alpha | (1.05) | |||
| Treynor Ratio | (0.46) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Oragenics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Oragenics February 16, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.11) | |||
| Market Risk Adjusted Performance | (0.45) | |||
| Mean Deviation | 3.61 | |||
| Coefficient Of Variation | (684.51) | |||
| Standard Deviation | 4.71 | |||
| Variance | 22.18 | |||
| Information Ratio | (0.16) | |||
| Jensen Alpha | (0.79) | |||
| Total Risk Alpha | (1.05) | |||
| Treynor Ratio | (0.46) | |||
| Maximum Drawdown | 24.7 | |||
| Value At Risk | (8.33) | |||
| Potential Upside | 7.32 | |||
| Skewness | 0.0853 | |||
| Kurtosis | 0.7228 |
Oragenics Backtested Returns
Oragenics maintains Sharpe Ratio (i.e., Efficiency) of -0.14, which implies the firm had a -0.14 % return per unit of risk over the last 3 months. Oragenics exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Oragenics' Risk Adjusted Performance of (0.11), coefficient of variation of (684.51), and Variance of 22.18 to confirm the risk estimate we provide. The company holds a Beta of 1.51, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Oragenics will likely underperform. At this point, Oragenics has a negative expected return of -0.69%. Please make sure to check Oragenics' total risk alpha, as well as the relationship between the skewness and day median price , to decide if Oragenics performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.42 |
Average predictability
Oragenics has average predictability. Overlapping area represents the amount of predictability between Oragenics time series from 18th of November 2025 to 2nd of January 2026 and 2nd of January 2026 to 16th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Oragenics price movement. The serial correlation of 0.42 indicates that just about 42.0% of current Oragenics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.42 | |
| Spearman Rank Test | 0.52 | |
| Residual Average | 0.0 | |
| Price Variance | 0.01 |
Pair Trading with Oragenics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Oragenics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Oragenics will appreciate offsetting losses from the drop in the long position's value.Moving together with Oragenics Stock
Moving against Oragenics Stock
| 0.75 | DSGN | Design Therapeutics | PairCorr |
| 0.68 | EQ | Equillium | PairCorr |
| 0.57 | DRTS | Alpha Tau Medical | PairCorr |
| 0.56 | DMAC | DiaMedica Therapeutics | PairCorr |
| 0.56 | SAB | Sonic Healthcare Earnings Call This Week | PairCorr |
The ability to find closely correlated positions to Oragenics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Oragenics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Oragenics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Oragenics to buy it.
The correlation of Oragenics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Oragenics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Oragenics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Oragenics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Oragenics Correlation, Oragenics Volatility and Oragenics Performance module to complement your research on Oragenics. To learn how to invest in Oragenics Stock, please use our How to Invest in Oragenics guide.You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Oragenics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.